dc.contributor.author |
Bedke, Jens |
|
dc.date.accessioned |
2021-12-20T09:30:40Z |
|
dc.date.available |
2021-12-20T09:30:40Z |
|
dc.date.issued |
2020 |
|
dc.identifier.issn |
1474-5488 |
|
dc.identifier.uri |
http://hdl.handle.net/10900/121874 |
|
dc.language.iso |
en |
de_DE |
dc.publisher |
Elsevier Science Inc |
de_DE |
dc.relation.uri |
http://dx.doi.org/10.1016/S1470-2045(20)30436-8 |
de_DE |
dc.subject.ddc |
610 |
de_DE |
dc.title |
Pembrolizumab plus axitinib versus sunitinib monotherapy as first-line treatment of advanced renal cell carcinoma (KEYNOTE-426): extended follow-up from a randomised, open-label, phase 3 trial |
de_DE |
dc.type |
Article |
de_DE |
utue.quellen.id |
20210304112512_00413 |
|
utue.publikation.seiten |
1563-1573 |
de_DE |
utue.personen.roh |
Powles, Thomas |
|
utue.personen.roh |
Plimack, Elizabeth R. |
|
utue.personen.roh |
Soulieres, Denis |
|
utue.personen.roh |
Waddell, Tom |
|
utue.personen.roh |
Stus, Viktor |
|
utue.personen.roh |
Gafanov, Rustem |
|
utue.personen.roh |
Nosov, Dmitry |
|
utue.personen.roh |
Pouliot, Frederic |
|
utue.personen.roh |
Melichar, Bohuslav |
|
utue.personen.roh |
Vynnychenko, Ihor |
|
utue.personen.roh |
Azevedo, Sergio J. |
|
utue.personen.roh |
Borchiellini, Delphine |
|
utue.personen.roh |
McDermott, Raymond S. |
|
utue.personen.roh |
Bedke, Jens |
|
utue.personen.roh |
Tamada, Satoshi |
|
utue.personen.roh |
Yin, Lina |
|
utue.personen.roh |
Chen, Mei |
|
utue.personen.roh |
Molife, L. Rhoda |
|
utue.personen.roh |
Atkins, Michael B. |
|
utue.personen.roh |
Rini, Brian, I |
|
dcterms.isPartOf.ZSTitelID |
Lancet Oncology |
de_DE |
dcterms.isPartOf.ZS-Issue |
12 |
de_DE |
dcterms.isPartOf.ZS-Volume |
21 |
de_DE |
utue.fakultaet |
04 Medizinische Fakultät |
de_DE |